A Controlled Study of Lithium vs. Chlorpromazine in Acute Schizophrenics
- 1 October 1971
- journal article
- clinical trial
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 119 (551) , 435-440
- https://doi.org/10.1192/bjp.119.551.435
Abstract
A previous double-blind controlled evaluation of lithium and chlorpromazine in both manic and schizo-affective individuals carried out in this unit (Johnsonet al., 1968) indicated that 85 per cent of the schizo-affectives showed a worsening of thought disorder when treated with lithium carbonate, the majority developing symptoms of an acute brain syndrome. The possibility of experimental design accounting for such treatment outcome must be considered.Keywords
This publication has 14 references indexed in Scilit:
- Neurotoxicity with Lithium: Differential Drug ResponsivenessInternational Pharmacopsychiatry, 1970
- Course of Endogenous Affective Psychoses and its Modification by Prophylactic Administration of Imipramine and LithiumInternational Pharmacopsychiatry, 1969
- LITHIUM TREATMENT ON ATYPICAL INDICATIONActa Psychiatrica Scandinavica, 1969
- Controlled evaluation of lithium and chlorpromazine in the treatment of manic states: An interim reportComprehensive Psychiatry, 1968
- Lithium Carbonate: A Clinical StudyAmerican Journal of Psychiatry, 1968
- Psychological test for psychopathology.Journal of Abnormal Psychology, 1968
- Lithium As a Prophylactic AgentArchives of General Psychiatry, 1967
- Imipramine and Thioridazine in Depressed and Schizophrenic PatientsJAMA, 1964
- The use of Lithium Salts in Affective DisordersThe British Journal of Psychiatry, 1963
- EVALUATION OF LITHIUM IN TREATMENT OF PSYCHOTIC EXCITEMENTThe Medical Journal of Australia, 1954